Straits Research Logo- p.jpg
Global Drug Infusion System Market Size Grows Steadily at a CAGR of 6.9%: Straits Research New York, United States, April 29, 2024 (GLOBE NEWSWIRE) -- A drug infusion system is a medical device that allows fluids, medicines, and therapeutic substances to be administered directly into a...
SeaStar Medical Provides Regulatory Update Related to its HDE Application for Pediatric Selective Cytopheretic Device
May 09, 2023 16:05 ET | SeaStar Medical Holding Corporation
DENVER, May 09, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation...
Zion Market Research.jpg
Global Methenamine Hippurate Tablets Market Size is Anticipated to Acquire 6.51% Billion by 2030 With CAGR of 6.51% | Pharmaceuticals Industry Analysis
April 14, 2023 08:06 ET | Zion Market Research
Houston, TX, April 14, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Methenamine Hippurate Tablets Market By Application (Healthcare-Associated UTIs And...
Qualigen Therapeutics Announces Pre-IND Feedback from U.S. Food and Drug Administration Regarding QN-302 for the Treatment of G4-Targeted Advanced Solid Tumors
December 07, 2022 09:10 ET | Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for...
gmi logo.jpg
Transradial Access Device Market revenue to cross USD 2.4 Bn by 2027: Global Market Insights Inc.
March 15, 2021 04:00 ET | Global Market Insights, Inc
Selbyville, Delaware, March 15, 2021 (GLOBE NEWSWIRE) -- According to latest report “Transradial Access Device Market by Product (Catheters, Guidewires, Sheath & Sheath Introducer,...
Vivos Inc Achieves Important Radiogel™ Development Milestones
June 24, 2020 07:30 ET | Vivos Inc.
Richland WA, June 24, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos announced today significant progress in its efforts to advance RadioGel™ for human therapy. Animal testing at the...
Logo new.jpg
Vivos Inc. Reports Progress
April 30, 2019 07:00 ET | Vivos Inc.
Richland WA, April 30, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCPINK: RDGL), provides an update on the progress towards commercialization of Y-90 IsoPet® for animal therapy. Animal...